‘CROWN JEWEL’: Pfizer CEO touts ‘TREMENDOUS SUCCESSES’ in oncology R&D
By
webmaster
3d agoen
Source
Whatfinger‘CROWN JEWEL’: Pfizer CEO touts ‘TREMENDOUS SUCCESSES’ in oncology R&Dwhatfinger.comPfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI’s transformative role in drug development on ‘Mornings with Maria.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #morningswithmaria #pfizer #albertbourla #bourla #health #healthcare #pharma #biotech #manufacturing #research #development #oncology #cancer #glp1 #artificialintelligence #ai [...] The post ‘CROWN JEWEL’: Pfizer CEO touts ‘TREMENDOUS SUCCESSES’ in oncology R&D appeared first on Whatfinger Business & Money .
You might also wanna read
AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation
AI drug discovery startup Chai Discovery, founded just 15 months ago, released an antibody-designing AI model that generated intense interes
forbes.com·1mo ago
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
STAT·1d ago
AstraZeneca shares vision of a green and AI-driven future
bioprocessintl.com·1d ago
A turning point for pancreatic cancer patients
statnews.com·1mo ago
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
STAT·5d ago
Aureka Opens Its Drug Discovery Model as AI Biotech Moves Toward Lab-Linked Systems
runtimewire.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.